31381523 30551653 33731741 31985471 30636742 34827603 32988468 33411248 35747889 31330281 28826192 35888737 33459656 31523487 29021617 32859763 35941373 30537908 32925082 30419368 30237454 33450382 36344508 36421479 31629852 29480206 32564227 3316759 - Search Results

Year	Number of Results
2016	1
2017	10
2018	14
2019	13
2020	22
2021	18
2022	15
2023	1

1

The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation.

Kayson E, Eberly S, Anderson KE, Marder K, Shoulson I, Oakes D, Young AB, Biglan K, Hersch S; Huntington Study Group PHAROS Investigators. Kayson E, et al. J Huntingtons Dis. 2019;8(4):435-441. doi: 10.3233/JHD-190365. J Huntingtons Dis. 2019. PMID: 31381523

2

Effect of Coenzyme Q₁₀ Supplementation on Testosterone.

Banihani SA. Banihani SA. Biomolecules. 2018 Dec 13;8(4):172. doi: 10.3390/biom8040172. Biomolecules. 2018. PMID: 30551653 Free PMC article. Review.

3

A high-throughput screening to identify small molecules that suppress huntingtin promoter activity or activate huntingtin-antisense promoter activity.

Khaled HG, Feng H, Hu X, Sun X, Zheng W, Li PP, Rudnicki DD, Ye W, Chen YC, Southall N, Marugan J, Ross CA, Ferrer M, Henderson MJ, Margolis RL. Khaled HG, et al. Sci Rep. 2021 Mar 17;11(1):6157. doi: 10.1038/s41598-021-85279-2. Sci Rep. 2021. PMID: 33731741 Free PMC article.

4

Baseline Variables Associated with Functional Decline in 2CARE, A Randomized Clinical Trial in Huntington's Disease.

McGarry A, McDermott MP, Kieburtz K, Peng J, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators. McGarry A, et al. J Huntingtons Dis. 2020;9(1):47-58. doi: 10.3233/JHD-190391. J Huntingtons Dis. 2020. PMID: 31985471 Free PMC article. Clinical Trial.

5

Disease-Modification in Huntington's Disease: Moving Away from a Single-Target Approach.

Jensen MP, Barker RA. Jensen MP, et al. J Huntingtons Dis. 2019;8(1):9-22. doi: 10.3233/JHD-180320. J Huntingtons Dis. 2019. PMID: 30636742 Review.

6

Cytotoxicity and Mitochondrial Effects of Phenolic and Quinone-Based Mitochondria-Targeted and Untargeted Antioxidants on Human Neuronal and Hepatic Cell Lines: A Comparative Analysis.

Fernandes C, Videira AJC, Veloso CD, Benfeito S, Soares P, Martins JD, Gonçalves B, Duarte JFS, Santos AMS, Oliveira PJ, Borges F, Teixeira J, Silva FSG. Fernandes C, et al. Biomolecules. 2021 Oct 29;11(11):1605. doi: 10.3390/biom11111605. Biomolecules. 2021. PMID: 34827603 Free PMC article.

7

Naturally occurring neuroprotectants in glaucoma.

Patel RP, Shamsher E, Hill D, Cordeiro MF. Patel RP, et al. Prog Brain Res. 2020;257:119-140. doi: 10.1016/bs.pbr.2020.06.022. Epub 2020 Jul 22. Prog Brain Res. 2020. PMID: 32988468

8

Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Morris G, Walker AJ, Walder K, Berk M, Marx W, Carvalho AF, Maes M, Puri BK. Morris G, et al. Mol Neurobiol. 2021 May;58(5):2158-2182. doi: 10.1007/s12035-020-02212-w. Epub 2021 Jan 7. Mol Neurobiol. 2021. PMID: 33411248 Review.

9

Suicidality Risk Factors Across the CARE-HD, 2CARE, and CREST-E Clinical Trials in Huntington Disease.

McGarry A, Auinger P, Kieburtz KD, Bredlau AL, Hersch SM, Rosas HD. McGarry A, et al. Neurol Clin Pract. 2022 Apr;12(2):131-138. doi: 10.1212/CPJ.0000000000001161. Neurol Clin Pract. 2022. PMID: 35747889

10

Characterization of unknown impurities in Coenzyme Q₁₀ using LC-MS and NMR.

Deng Y, Chen X, Wang L, Peng X, Lin M. Deng Y, et al. J Pharm Biomed Anal. 2019 Oct 25;175:112771. doi: 10.1016/j.jpba.2019.07.019. Epub 2019 Jul 14. J Pharm Biomed Anal. 2019. PMID: 31330281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results